High Sensitivity of FISH Analysis in Detecting Homozygous SMARCB1 Deletions in Poorly Differentiated Chordoma: A Clinicopathologic and Molecular Study of 9 Cases

Abstract

Poorly differentiated chordomas (PDCs) represent a rare subset of notochordal neoplasms, affecting primarily children and associated with an aggressive outcome. In contrast to conventional chordomas, PDC show solid growth and increased cellularity, cytologic atypia, and mitotic activity. Recent studies have shown that PDCs are characterized by recurrent deletions encompassing the SMARCB1 locus, resulting in consistent loss of nuclear SMARCB1 expression. Thus PDC joined the expanding family of SMARCB1-deficient tumors characterized by various SMARCB1 structural abnormalities, ranging from large homozygous deletions to small intragenic mutations. In the present study we investigate the SMARCB1 abnormalities in a group of 9 well characterized PDCs and to establish the sensitivity of FISH method in detecting these changes in the clinical setting. We further assessed the pathologic features and clinical behavior of this cohort managed at our referral center over a 20-year period. The mean age at diagnosis was 10 years-of-age. All except one case occurred in the cranial region. All demonstrated strong nuclear expression of brachyury and loss of SMARCB1 expression. FISH identified homozygous SMARCB1 deletions in all except one case; additionally 2 cases revealed a heterozygous EWSR1 locus co-deletion. Clinical follow-up information was available in 5 patients. Two patients presented with distant metastases at initial diagnosis. Two of the 3 remaining patients with primary disease failed both locally and distantly after multimodality therapy. We conclude that PDC are highly aggressive tumors and the dominant mechanism of loss of SMARCB1 expression is through large, homozygous SMARCB1 deletions that can be readily detected by FISH. This article is protected by copyright. All rights reserved.

http://ift.tt/2jdk8Ce